Bone marrow transplant (BMT) can be a life-saving procedure for children diagnosed with cancers and serious blood disorders. But how should families prepare? What physical, emotional, and ...

A new editorial perspective was published in Volume 17 of Oncotarget on February 20, 2026, titled "CAR-T therapy: Trailblazing CAR(ing) in cancer treatment." ...

This study reveals a strong association between early mental health disorders in cancer patients and increased all-cause mortality, highlighting care needs.

Bionano Symposium 2026 continues with Day 2: New Frontiers in Oncology and Bioprocessing Applications on February 24, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...

While not every patient with AML develops skin involvement, it can be one of the earliest visible signs that something systemic is occurring.

Kymera Therapeutics develops targeted protein degradation therapies for immunology, oncology, and fibrosis using proprietary ...

Arcellx develops next-generation cell therapies targeting multiple myeloma and other hematologic cancers in the biotechnology sector.

The CAR T-cell therapy market is ripe for growth with over 250 companies and 500 drugs in development globally. Key opportunities lie in targeting hematologic malignancies and overcoming challenges in ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/trial-workflows ...

The growth of the BCL-2 inhibitors market is expected to be driven primarily by rising incidence, increased awareness and access to treatment, and the launch of emerging drugs such as Lisaftoclax ...